McNicol M - Search Results

1

Proactive therapeutic drug monitoring and vedolizumab dose optimization in children with inflammatory bowel disease.

Rowland P, McNicol M, Kiel A, Maltz RM, Donegan A, Dotson JL, Michel HK, Boyle B. Rowland P, et al. Among authors: mcnicol m. J Pediatr Gastroenterol Nutr. 2024 Apr;78(4):853-861. doi: 10.1002/jpn3.12132. Epub 2024 Jan 25. J Pediatr Gastroenterol Nutr. 2024. PMID: 38270212

2

Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money.

Morris GA, McNicol M, Boyle B, Donegan A, Dotson J, Michel HK, Maltz RM. Morris GA, et al. Among authors: mcnicol m. Inflamm Bowel Dis. 2022 Mar 30;28(4):531-538. doi: 10.1093/ibd/izab110. Inflamm Bowel Dis. 2022. PMID: 34037215

3

The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model.

Michel HK, Boyle B, David J, Donegan A, Drobnic B, Kren C, Maltz RM, McKillop HN, McNicol M, Oates M, Dotson JL. Michel HK, et al. Among authors: mcnicol m. Inflamm Bowel Dis. 2022 Sep 1;28(9):1420-1429. doi: 10.1093/ibd/izab238. Inflamm Bowel Dis. 2022. PMID: 34562013 Review.

4

Patient and Caregivers' Perspectives on Biosimilar Use in Pediatric Inflammatory Bowel Disease.

Yossef L, Wright M, Benedict J, Morris GA, McNicol M, Boyle B, Dotson JL, Michel HK, Maltz RM. Yossef L, et al. Among authors: mcnicol m. J Pediatr Gastroenterol Nutr. 2022 Jul 1;75(1):59-63. doi: 10.1097/MPG.0000000000003462. Epub 2022 Apr 20. J Pediatr Gastroenterol Nutr. 2022. PMID: 35442227

5

There Is No Substitute for Effective Education About Biosimilars.

Maltz RM, McNicol M, Wingate L, Buchanan S, Sandell A, Kim SC, Rubin DT. Maltz RM, et al. Among authors: mcnicol m. Crohns Colitis 360. 2021 Jul 7;3(4):otab047. doi: 10.1093/crocol/otab047. eCollection 2021 Oct. Crohns Colitis 360. 2021. PMID: 36777278 Free PMC article. No abstract available.

6

Maltz RM, McClinchie MG, Boyle BM, McNicol M, Morris GA, Crawford EC, Moses J, Kim SC. Maltz RM, et al. Among authors: mcnicol m. J Pediatr Gastroenterol Nutr. 2023 May 1;76(5):616-621. doi: 10.1097/MPG.0000000000003750. Epub 2023 Feb 23. J Pediatr Gastroenterol Nutr. 2023. PMID: 36827968

7

McClinchie MG, Lakhani A, Abdel-Rasoul M, McNicol M, Shkhkhalil AK, Boyle BB, Maltz RM. McClinchie MG, et al. Among authors: mcnicol m. J Pediatr Gastroenterol Nutr. 2023 Oct 1;77(4):499-504. doi: 10.1097/MPG.0000000000003890. Epub 2023 Sep 20. J Pediatr Gastroenterol Nutr. 2023. PMID: 37439588

8

Clinical outcomes and cost savings of a nonmedical switch to a biosimilar in children/young adults with inflammatory bowel disease.

McNicol M, Abdel-Rasoul M, McClinchie MG, Morris GA, Boyle B, Dotson JL, Michel HK, Maltz RM. McNicol M, et al. J Pediatr Gastroenterol Nutr. 2024 Mar;78(3):644-652. doi: 10.1002/jpn3.12153. Epub 2024 Feb 9. J Pediatr Gastroenterol Nutr. 2024. PMID: 38334232

9

Evaluation of a remote hybrid staffing model for ambulatory clinical pharmacists in a pediatric health system during the COVID-19 pandemic.

Baron K, Herbst J, McNicol M, Stephan E, Abdel-Rasoul M, Wise K. Baron K, et al. Among authors: mcnicol m. Am J Health Syst Pharm. 2022 May 24;79(11):852-859. doi: 10.1093/ajhp/zxac022. Am J Health Syst Pharm. 2022. PMID: 35088067 Free PMC article.

10

Impact of pharmacist alternative therapy interventions in a pediatric Medicaid population.

McNicol MC, Wheaton K, Abdel-Rasoul M, Monangai KE, Sebastian S. McNicol MC, et al. J Manag Care Spec Pharm. 2023 Jul;29(7):835-841. doi: 10.18553/jmcp.2023.29.7.835. J Manag Care Spec Pharm. 2023. PMID: 37404069 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters